Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Astrazeneca Plc Ord (OP: AZNCF ) 159.76 UNCHANGED Streaming Delayed Price Updated: 3:45 PM EDT, Aug 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Astrazeneca Plc Ord < Previous 1 2 3 4 5 6 7 8 Next > AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, In Expert Review July 13, 2022 Via Benzinga Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out July 13, 2022 Via Benzinga Drugmakers, Health Authorities Discarding Several Million COVID-19 Vaccine Doses: Report July 06, 2022 Via Benzinga AstraZeneca's COVID-19 Treatment Allowed In China's Southern City: Reuters July 06, 2022 Via Benzinga AstraZeneca Strengthens Its Hematological Cancer Pipeline With TeneoTwo Acquisition July 05, 2022 AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire< Via Benzinga AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s) May 17, 2022 Via Benzinga AstraZeneca's Combination Inhaler Shines In Phase 3 Asthma Trial May 16, 2022 Via Benzinga The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact July 01, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants July 01, 2022 Via Benzinga Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine July 01, 2022 Via Benzinga AstraZeneca Says Imfinzi/Chemo Combo Shows Promising Action In Late-Stage Lung Cancer Study June 30, 2022 Via Benzinga The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies June 27, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies June 27, 2022 Via Benzinga AstraZeneca's ALXN1840 Shows Promising Action Against Copper Metabolism Disorder June 23, 2022 Via Benzinga AstraZeneca - Ionis Eplontersen Achieves Positive Data In Rare Disease Trial June 21, 2022 Via Benzinga Why Mereo BioPharma Shares Are Jumping Today June 17, 2022 Via Benzinga AstraZeneca-Daiichi Breast Cancer Drug Cuts Disease Progression Or Death Risk By Almost 50% June 06, 2022 Via Benzinga European Regulator Approves AstraZeneca's COVID-19 shot As Booster May 23, 2022 Via Benzinga Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco May 11, 2022 Via Benzinga Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV May 11, 2022 Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV). Via Benzinga FDA Approval For AstraZeneca - Daiichi's Enhertu Expands To Earlier Use In Metastatic Breast Cancer May 05, 2022 Via Benzinga The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study May 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga AstraZeneca's Imfinzi/Chemo Combo Goes Under Priority FDA Review For Bile Duct Cancer May 04, 2022 Via Benzinga AstraZeneca Clocks Q1 COVID Vaccine Sales Of $1.2B, Keeps Overall FY22 Outlook April 29, 2022 Via Benzinga Daiichi Sankyo - AstraZeneca's Enhertu Receives Third Breakthrough Therapy Tag In Breast Cancer April 27, 2022 Via Benzinga AstraZeneca's Tremelimumab/Imfinzi Combo Regime Goes Under Priority FDA Review For Liver Cancer April 25, 2022 Via Benzinga World's Largest Vaccine Manufacturer Stops Making COVID-19 Vaccines As 200M Doses Pile-Up: Bloomberg April 22, 2022 Serum Institute of India Ltd, the world’s largest vaccine manufacturer, has stopped making new batches of COVID-19 shots after its stockpile grew to 200 million doses amid a global supply glut, Via Benzinga The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data April 21, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga AstraZeneca's COVID-19 Antibody Provides Protection For At Least Six Months In High-Risk Individuals April 21, 2022 Via Benzinga UK-Based Start-Up Working On Next COVID-19 Vaccine Using Animal Feces: FT April 19, 2022 Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.